Eurofarma Laboratorios S.a.
Clinical trials sponsored by Eurofarma Laboratorios S.a., explained in plain language.
-
New asthma inhaler faces off against standard treatment in major trial
Disease control Not yet recruitingThis study tests a new inhaler medicine (N0783) to see if it works as well as a standard inhaler (Alenia) for people with moderate asthma. About 174 adults will take part. The main goal is to check if the new drug controls asthma and improves lung function just as well as the cur…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New hair loss pill enters final testing phase
Disease control Not yet recruitingThis study tests an oral medication (N1087, a form of minoxidil) against a placebo in 372 men aged 18 to 60 with moderate male pattern baldness. Participants take a pill once daily for 24 weeks, starting with a low dose that increases over the first 8 weeks. The goal is to see if…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
New drug aims to regrow hair in women with pattern baldness
Disease control Not yet recruitingThis study tests a new medicine called N1087 for women with female pattern hair loss. About 372 women will take either the drug or a placebo daily for 24 weeks. The goal is to see if the drug increases hair density and thickness in the scalp area. Researchers will also check safe…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC